Universal Health Services (UHS) Goldman Sachs 45th Annual Global Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
Goldman Sachs 45th Annual Global Healthcare Conference summary
22 Jan, 2026Acute care market trends
Acute care volumes have been strong in Q2, slightly above expectations, with March softness attributed to calendar dynamics.
Elevated utilization is mainly driven by the Medicare population, particularly in medical admissions rather than surgical.
There is caution about the sustainability of current volume growth, with expectations for moderation over time.
Strategic planning and capital allocation
Capital deployment is focused on diversifying across the care continuum, not just on acute care admission growth.
Expansion of freestanding emergency departments has relieved pressure on hospital ERs and improved patient access.
The shift from inpatient to outpatient care has been ongoing for over a decade, with outpatient surgical growth outpacing inpatient.
Revenue and reimbursement dynamics
Revenue per adjusted admission remains strong, supported by Medicaid supplemental payments and commercial pricing.
Supplemental Medicaid programs are expected to remain stable or grow, as providers depend on them for financial survival.
Commercial contract renewals since mid-2022 have achieved higher price increases, with limited payer pushback on pricing.
Payer denials and patient status changes increased post-pandemic but have stabilized; no significant impact from the Two-Midnight Rule yet.
Latest events from Universal Health Services
- Talkspace acquisition and AI investments drive outpatient growth and operational efficiency.UHS
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Acquisition of Talkspace boosts outpatient behavioral health and virtual care capabilities.UHS
Leerink Global Healthcare Conference 20269 Mar 2026 - 2026 guidance targets 2%-3% volume growth, with focus on staffing, outpatient, and AI initiatives.UHS
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Strong 2025 growth and higher 2026 outlook, with regulatory and funding risks ahead.UHS
Q4 202526 Feb 2026 - Director elections and auditor ratification passed; annual director election proposal failed.UHS
AGM 20253 Feb 2026 - Q2 net income surged 69% and 2024 guidance was raised; $1B added to share repurchase.UHS
Q2 20242 Feb 2026 - Margin recovery and growth are driven by volume gains, cost controls, and supplemental programs.UHS
2024 Wells Fargo Healthcare Conference22 Jan 2026 - Margin recovery and EBITDA growth driven by Medicaid programs, cost control, and strong pricing.UHS
Baird 2024 Global Healthcare Conference21 Jan 2026 - Double-digit profit and revenue growth, margin recovery, and legal risks persist.UHS
Q3 202418 Jan 2026